All lobbying filings

Kamran Daravi Consulting LLC

Kamran Daravi Consulting LLC filed a Q4 amendment for Monticello Group, LLC on Behalf of Detroit Biopharma on July 16, 2026, reporting $10,000 in lobbying income.

Lobbying for Monticello Group, LLC on Behalf of Detroit Biopharma · Government Relations and Business Development Advisory Firm

As filed: KAMRAN DARAVI CONSULTING LLC for MONTICELLO GROUP, LLC ON BEHALF OF DETROIT BIOPHARMA.

All filings by Kamran Daravi Consulting LLC · Everything Monticello Group, LLC on Behalf of Detroit Biopharma has reported

Filing · LD-2 quarterly report Q4 amendment

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jul 16, 2026

Income

$10,000

What the client paid this registrant for the period.

Client based in

Maryland

Official filing document

Lobbyists on this filing 1

KAMRAN DARAVI

Previously held: U.S. Presidential Transition Team 2016-2017; Advisor for Global Affairs, U.S. Department of Health & Human Services 2017-2018; Senior Advisor, U.S. Dept. of State 2018-2019; Policy Advisor, Domestic Policy Council, The White House 2019-2021

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 1

Health & Human Services, Dept of (HHS)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Manufacturing

Biopharma manufacturing, improve industrial supply chain to address shortages, advance technology, improve patient outcomes.

Health Issues

Biopharma manufacturing, improve industrial supply chain to address shortages, advance technology, improve patient outcomes.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.